Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy With No Retroperitoneal Node Dissection in Apparent Early-Stage Endometrial Cancer

NCT04073706 is registered in ClinicalTrials.gov with Queensland Centre for Gynaecological Cancer as lead sponsor.

NCT NCT04073706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04073706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy With No Retroperitoneal Node Dissection in Apparent Early-Stage Endometrial Cancer
Lead sponsor
Queensland Centre for Gynaecological Cancer
Phase
Phase 3
Overall status
Recruiting
Start date
January 18, 2021
Completion date
February 28, 2031
Enrollment
760 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer stage i, sentinel lymph node, surgery